The postsynaptic proteome of excitatory synapses comprises ~1,000 highly conserved proteins that control the behavioral repertoire, and mutations disrupting their function cause > 130 brain diseases. Here, we document the composition of postsynaptic proteomes in human neocortical regions and integrate it with genetic, functional and structural magnetic resonance imaging, positron emission tomography imaging, and behavioral data. Neocortical regions show signatures of expression of individual proteins, protein complexes, biochemical and metabolic pathways. We characterized the compositional signatures in brain regions involved with language, emotion and memory functions. Integrating large-scale GWAS with regional proteome data identifies the same cortical region for smoking behavior as found with fMRI data. The neocortical postsynaptic proteome data resource can be used to link genetics to brain imaging and behavior, and to study the role of postsynaptic proteins in localization of brain functions.
F
or almost two centuries, scientists have pursued the study of localization of function in the human cerebral neocortex using diverse methods including neuroanatomy, electrophysiology, imaging and gene expression studies. The frontal, parietal, temporal and occipital lobes of the neocortex have been commonly subdivided into Brodmann areas (BAs) 1 on the basis of cytoarchitectural features, and specific behavioral functions have been ascribed to these regions. One of the hallmarks of the neocortex is its high density of excitatory synaptic connections 2 . These synapses are endowed with over 1,000 postsynaptic proteins that control the behavioral repertoire and are disrupted by mutations causing over 130 brain diseases 3, 4 . However, the compositional and functional differences in synapse proteomes in the neocortical regions remains unknown. The recent development of reliable methods for the direct quantification of human neocortical synapse proteomes from post-mortem tissue makes it feasible to analyze the molecular composition of synapses directly in human brain regions 5 . In the last two decades, proteomic mass spectrometry has been used to systematically characterize the protein composition of synapses and has expanded our view of the postsynaptic terminal from being a simple connector to a sophisticated signaling machine 6, 7 assembled from multiprotein complexes and supercomplexes [8] [9] [10] [11] [12] .
The characterization of the postsynaptic proteome in humans [3] [4] [5] , mice 3, 13 , rats [14] [15] [16] and zebrafish 17 reveals a highly conserved vertebrate postsynaptic density proteome 17 comprising ~1,000 proteins. In addition to these conserved proteins, there are lineage-specific postsynaptic proteins that contribute to functional variation 17 . It is also evident that there must be compositional differences in the synapse proteome across different brain regions because immunohistochemical staining of individual synaptic proteins shows nonuniform distributions 18 . Studying brain regional variation in synapse proteomes is important because these large and comprehensive datasets can be used with genetic and anatomy-based resources, such as the Human Connectome Project 19 , to better understand the localization of neocortical functions including behavior.
Here we generate a map of the human postsynaptic proteome across frontal, parietal, temporal and occipital lobes of the neocortex, focusing on 12 BAs (Fig. 1a and Table 1 ). These BAs are involved in many aspects of behavior, including executive functions, language, motor functions, vision and memory. Localized pathology in these regions is associated with many disorders, including schizophrenia, dementias, stroke, trauma and substance abuse. We show that diversity in the composition of postsynaptic density (PSD) proteins generates a characteristic molecular signature for each BA. Integration of these data with genetic, positron emission tomography (PET), and functional and structural magnetic resonance imaging (MRI) data shows that synapse proteome data can be used to address a variety of questions about the localization of functions in the neocortex. The large-scale dataset we describe and make freely available will be a resource for a wide range of future studies on the human brain, behavior and brain imaging.
Results
Isolation of the postsynaptic proteome from neocortex. Postmortem human brain tissue obtained from the UK Medical Research Council's Edinburgh Brain Bank was screened for synaptic proteome preservation using HUSPIR (the human synapse proteome integrity ratio) 5 , and four non-diseased samples suitable for synapse proteomics were identified (Supplementary Table 1 ). We focused on 12 BAs, from frontal, parietal, temporal and occipital lobes of the neocortex ( Fig. 1a and Table 1 ). A wide range of behavioral functions has been ascribed to these areas ( Table 1 ). The PSD fraction was isolated from each tissue sample as previously described 5 and liquid chromatography and tandem mass spectrometry (LC-MS/ MS) analysis performed on a total of 48 samples. Label-free quantification of peptide intensity for all proteins identified 1,213 proteins (Supplementary Table 2 ). Proteins identified with a minimum of two unique peptides and having a mean peptide intensity difference of 1.5-fold or greater in one brain region compared to any other and determined to be significant at P < 0.05 were scored as differentially expressed (Supplementary Table 2 ). One hundred forty-nine proteins were differentially expressed in at least one BA compared to all others (Supplementary Fig. 1 and Supplementary Table 3) .
We first compared the complexity of this proteome dataset with that of two previously published human postsynaptic proteome neocortex datasets 4, 5 and found an overlap of 75% between the three ( Supplementary Fig. 2a ). Twenty-five percent of proteins in this study had not been previously detected (Supplementary Table 4) , which may reflect the many new BAs investigated. Consistent with this, we compared our human dataset with whole forebrain datasets obtained in mice and rats and found a 96.3% overlap ( Supplementary  Fig. 2b ). Thus, the sampling of 12 BAs across the human neocortex likely captures the diversity of postsynaptic proteins found in the mammalian brain.
Validation of pooling of individual samples.
Prior to pooling datasets from the individuals, we examined reproducibility of expression between individuals using the differential stability (DS) approach that was previously applied in the transcriptome analysis of adult human brain regions 20 . DS analysis was performed on the MS intensity values obtained for the 1,213 proteins to identify the subset with highly reproducible expression patterns across the four independent human brains. As in Hawrylycz et al. 20 , we quantified the average pairwise Pearson correlation ρ over a set of 12 anatomical regions and obtained the DS values ranging from 0.83 to − 0.25, with 37 proteins (3% of total) having a ρ ≥ 0.5, highly correlated among all four individuals (Supplementary Table 5 , where q is the P-value adjusted for multiple testing) and calcium-dependent membranetargeting proteins (q = 5.83 × 10 −3
) (Supplementary Table 6 ). We next asked whether these high-DS proteins corresponded to the transcripts identified as having high DS in the transcriptome analysis of human brain regions 20 and found a very high overlap (35 of 37; 95%, P = 2.04 × 10
−16
). Although the total percentage of high-DS samples is higher in the transcriptome analysis 20 , the estimated correlation coefficient between the DS results for all postsynaptic proteins and their respective transcripts was small (R 2 = 0.18) but highly significant (P = 1.218 × 10
−9
). As a second approach, we examined differences between the brain regions of all four individuals by performing hierarchical clustering on protein abundances ( Supplementary Fig. 3 ). The 12 BAs clustered into two main branches: one large branch containing seven or eight similar regions and a second branch of three or four similar regions. In addition, Tukey's honestly significant difference (HSD) test showed no significant difference between the mean values of four individuals at a confidence level of 95% ( Supplementary Fig. 4a,b) . We also examined the effect of removing brain B (female) or brain D (longest post-mortem interval) on biochemical modules. Although this perturbed some modules (specifically, modules 5 and 6), we noticed that combining these brains mutually compensated for this disturbance (see below and Supplementary Fig. 5 ). We therefore decided to proceed with combined data from all four individuals. Individual proteins and their abundances across all 12 BAs are listed in Supplementary Tables 7 and 8 (ranked regional abundance different functions in neocortical regions, we sought to identify the invariant proteins that may provide core functions in all 12 BAs. Using the method of Le Bihan et al.
21
, we performed two one-sided t-tests (the TOST test) using mean MS intensity values (n = 4) for the 1,213 proteins and an ε sensitivity factor (see Methods) of 0.045. This identified 27 proteins (Supplementary Table 9 ). The proteins with the lowest variability between regions were ANK3 (P = 0.008), RHOT1 (P = 0.012), MYO18A (P = 0.015) and DYNCLI1 (P = 0.018). The 27 proteins were enriched in components of the cytoskeleton (q = 8.91 × 10 Table 10 ). This indicates that this set of postsynaptic proteins with the lowest variability between brain regions is enriched in key structural elements of the cytoskeleton and is representative of a universal core of proteins that maintain the structural integrity of the postsynaptic proteome throughout the neocortex.
Neocortical architecture of the postsynaptic proteome. We proceeded to study the differences between brain regions using a series of analyses beginning with candidate proteins of known functional importance and then proceeding to methods that exploit the large datasets to identify a modular molecular architecture of the postsynaptic proteome that underpins regional organization. We first examined the expression of 41 well-known candidate proteins representing 11 protein classes including glutamate and GABA receptors, scaffold proteins and other ion channels, which are known to play a key role in synaptic physiology and cognitive functions (Supplementary Table 11 ). AMPA receptors are protein complexes that mediate fast synaptic transmission, and we found GRIA1 (also known as AMPA1) to be differentially expressed throughout the neocortex. It was most abundant in BA20 and least abundant in BA4, having z-scores of 0.24 and 0.34 above the mean, respectively. Conversely, two other AMPA receptor subunits, GRIA3 (AMPA3) and GRIA4 (AMPA4), were detectable at very low levels and uniformly in all regions examined, with average z-scores of − 0.6 and − 0.7 below the mean, respectively. The NMDA receptor subunits, which also assemble protein complexes 9, 12 and mediate synaptic plasticity, were differentially expressed: GRIN1 (NR1) and GRIN2B (NR2B) were least abundant in BA4 and BA19 and highly abundant in BA20. NMDA receptor complexes assemble with MAGUK (membrane-associated guanylate kinase) scaffold protein complexes to form supercomplexes 9, 12 , and paralogs of this family-DLG1 (SAP97), DLG2 (PSD93, DLG3 (SAP102) and DLG4 (PSD95)-were also differentially abundant across all regions (Supplementary Table 11 ). These findings indicate that different regions of the neocortex express differing amounts of synaptic proteins and their complexes.
We next used the full complement of proteome data and hierarchical clustering to compare BAs. This approach allows us to group BAs into those that are similar and different in terms of PSD protein expression, as well as identify subsets (or modules) of postsynaptic proteins that are co-regulated in the BAs. Each BA had a distinct molecular signature, and the similarities of these signatures was hierarchically organized into groups, including four main branches that we refer to as Brodmann area groups (BAGs 1-4) (Figs. 1b,c) . Several organizational principles emerge. First, there is diversity of postsynaptic proteomes in all four lobes of the cerebrum (frontal, temporal, parietal and occipital). Second, two regions from different lobes can be more similar to each other than two adjacent regions in the same lobe. For example, BA19 from the occipital lobe is similar to BA4 and BA6 in the frontal lobe (all are in BAG1), but distinct from its adjacent regions BA37 and BA39 (in BAG4). Third, adjacent regions can either be similar or different; of ten pairs of adjacent BAs, four were in the same BAG. The similar pairs of adjacent regions were temporal lobe areas BA20 (inferior temporal area) and BA38 (anterior temporal lobe), both in BAG2; dorsolateral prefrontal cortex area BA9 and pars opercularis of the inferior frontal gyrus BA44; primary motor cortex BA4 and premotor cortex BA6; the angular area of the parietal cortex BA39 and the occipitotemporal area BA37 of the occipital lobe. These findings indicate that postsynaptic proteome compositional differences contribute to the diversity of BAs and that this reveals a hierarchical relationship among these areas. To understand how this anatomical organization arises from the differential expression of postsynaptic proteins, we identified clusters of co-regulated groups of postsynaptic proteins, which we call postsynaptic proteome modules (PPMs) (Fig. 1b and Supplementary Table 12 ). The seven PPMs were selected on the basis of the best combination of indices provided by the nbClust R package (Methods). To validate the robustness of these PPMs, we performed bootstrapping with hClust, k-means clustering and the pam method (Methods and Supplementary Fig. 4a ). To visualize the distribution of the different PPMs across the 12 BAs, Circos visualization was performed using those proteins whose abundances are above the mean and thus enriched (having a positive z-score in their protein abundance trends for a given region compared to all other regions analyzed) (Supplementary Fig. 6 ). We found that while certain PPMs exhibited only subtle differences in distribution, others, such as PPM1 and PPM2, showed very different abundance patterns between brain regions. PPM1 contained NMDA receptor subunits GRIN1 and GRIN2B and PPM2 contained MAGUK proteins DLG4, DLG3 and DLG2, which assemble multiprotein signaling complexes 9, 12 controlling synaptic plasticity. We also found that key components of inhibitory synapses were also part of differentially distributed protein modules: PPM1 contained GABRB1, GABRB3 and GABBR2; PPM2 contained GABRA1, GABRB2 and GABARAPL2; PPM6 contained GABBR1, GABRA2 and GABRG2. Taken together, these results demonstrate that differential distribution of PPMs and their key functional proteins contributes to the hierarchical organization of BAs.
Electrophysiological validation of proteome differences in BAs.
To test the functional significance of the differential expression of synaptic molecules in BAs, we examined the electrophysiological properties of Xenopus oocytes injected with synaptosomes isolated from frozen human brain tissue 22 . We specifically examined the β 1 GABA A receptor subunit between regions BA20 and BA39 and between regions BA4 and BA19 (Fig. 2 ). BA20 and BA39 were chosen because they were the two regions showing the largest differential expression, in contrast to BA4 and BA19, which showed small differential expression (see GABRB1 differential distribution in Supplementary Tables 9 and 10). Similar amounts of synaptosomes from BA20 and BA39 were injected into oocytes, and 2 d later ion currents were measured using the two-electrode voltage clamp technique. Application of 1 mM GABA agonist resulted in much larger responses (P < 0.0001, unpaired t-test) in oocytes injected with synaptosomes from BA20 (82 ± 2 nA; n = 6) than in oocytes injected with synaptosomes from BA39 (35 ± 5 nA; n = 6) (Fig. 2a) . Similar results were obtained with synaptosomes from the same two brain regions obtained from two other brain donors. In these two further cases, 1 mM GABA-induced responses were 25 ± 2 nA (n = 7) for BA20 and 3 ± 1 nA (n = 7) for BA39 for one donor, and 9 ± 3 nA (n = 7) for BA20 and 1.4 ± 0.4 nA (n = 8) for BA39 for the other donor (Fig. 2a) . In contrast to BA20 versus BA39 differences, no significant differences in 1 mM GABA-evoked responses were found between BA4 and BA19, the two brain regions with similar β 1 GABA A subunit protein levels (Fig. 2b) . Different ion currents between donors is expected given the variation in quality of the original tissues 22 . These electrophysiological experiments indicate that the differential synaptosome proteome composition reflects functional differences in ion channel activity in BAs.
Neocortical localization of biochemical pathways. We next turned our attention from ion channels and receptor mechanisms to the wider range of postsynaptic biochemical functions found in the highly complex proteome and asked whether these functions showed differential neocortical localization. We used two related strategies: KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analysis of PPMs or of the ranked abundance of proteins in each BA. The results for the first strategy reveal differential biochemical pathway enrichment in PPMs (Fig. 3a) . For example, PPM1 was enriched in synaptic vesicle functions and synaptic plasticity (long-term potentiation and depression pathways), whereas PPM7 was particularly enriched in oxidative phosphorylation and Alzheimer's, Parkinson's and Huntington's disease pathways. In the second strategy, KEGG pathway enrichment was performed on the ranked protein abundances for each of the 12 BAs and hierarchical clustering performed (Fig. 3b) . Complementarily to the organization of BAGs (Fig. 1b) , which were based on abundance of proteins, we find that each BA has a unique biochemical 'pathway signature' (Fig. 3b) . Notably, the dendrogram shows three main divisions: (i) many signal transduction mechanisms, (ii) synaptic plasticity and other signaling processes, and (iii) neurodegenerative diseases and metabolic mechanisms.
PET imaging of postsynaptic metabolic mechanisms. Human brain imaging is the main tool for examining the localization of functions in the human neocortex. We sought to investigate the possibility that regional differences in the postsynaptic proteome are relevant to brain imaging. PET has been used to document differences between BAs for several metabolic parameters in normal resting human subjects, including cerebral metabolic rate for oxygen (CMRO 2 ), cerebral metabolic rate for glucose (CMRGlu), cerebral blood flow, and two derived indices (oxygen-glucose index, OGI; glycolytic index, GI) 23 . The postsynaptic density is known to contain glycolytic and other metabolic enzymes that generate ATP used by signaling enzymes involved with synaptic plasticity 3, 4, 13, 14, 16, 24 . Using published PET data 23 reporting metabolic parameters from brain regions (spatial resolution 3-5 mm), we correlated these metabolic data with protein abundances in the PPMs and found significant correlations that were robust to perturbation analysis (n regions = 12,
) ( Fig. 4a and Methods). For example, the mean regional protein abundance of PPM1 (which contains high levels of the mitochondrial complex I and IV proteins and enzymes involved in the oxidative phosphorylation pathway) correlated positively with the OGI value and negatively with GI, CMRGlu and CMRO 2 values; the mean regional protein abundances for PPMs 2 and 3, which contain PGAM glycolytic enzymes and PKM proteins, correlated positively with values of these metabolic parameters. These findings indicate that regional differences in the composition of the postsynaptic proteome correlate with functional signals measured in PET metabolic imaging.
Task-specific fMRI signals correlate with regional postsynaptic proteomes. MRI is another imaging modality that is widely used to study structural and functional organization of the neocortex. Behavioral responses can be detected in regions of the neocortex using functional MRI (fMRI), and postsynaptic proteins are important for many human behaviors 4 . We therefore hypothesized that compositional differences between the postsynaptic proteomes in different BAs would be linked to specific behavioral responses detected with fMRI. To test this hypothesis, we obtained data from the Human Connectome Project (HCP), which used high-quality MRI data to define the structural and functional parcellation of neocortical regions 19 . The HCP uses myelin content and cortical thickness from MRI images to define the structural architecture of neocortex and has mapped correlates with the functional activation of brain regions in response to a battery of behavioral tests, called task fMRI (tfMRI). These tasks activate well-characterized neural systems including (1) visual and somatosensory-motor systems, (2) category-specific representations, (3) language function (semantic and phonological processing), (4) attention systems, (5) working memory and cognitive control systems, (6) emotion processing, (7) decision-making and reward processing, and (8) episodic memory systems 25 (see Methods and Supplementary Table 13 for the nomenclature of the specific tasks).
We first identified the parcellated regions from the HCP that corresponded to the 12 BAs ( Supplementary Fig. 7 and Methods). The fMRI structural marker "myelin" showed a high correlation with the expression values of four myelin proteins (MOG, PLP1, OMG and PMP2) in our proteomic data (R 2 = 0.7-0.8, P < 0.0001) ( Supplementary Fig. 7a and Supplementary Table 14) . Next we computed the correlation of the behavioral tfMRI scores (19 scores) with proteome expression abundances (1,213 proteins) over 12 BAs (Fig. 4b and Supplementary Table 15 ). Perturbation analysis identified 1,154 significant (q < 0.05) scores (Supplementary Table 16 ). We then performed hierarchical clustering of all HCP structural (myelin and cortical thickness) and behavioral scores from the fMRI datasets with postsynaptic protein abundance and found a clear division into four quadrants (Fig. 4b) .
Strikingly, the structural and functional fMRI traits were separated into two main groups: language and motor functions were clustered with the myelin structural marker, whereas emotion and working memory were clustered with the cortical thickness marker. To further explore the biochemical features of the postsynaptic proteomes associated with these behavioral traits, we correlated tfMRI scores with PPM protein abundances (similarly to the PET analysis above) and found significant correlations that were robust to perturbation analysis (n regions = 12, q < 0.05) (Supplementary Fig. 8 ). PPM5, which contains the four myelin proteins in our study (MOG, PLP1, OMG and PMP2), correlated with the myelin structural marker. Other PPMs correlated with behavioral tasks; for example, language/mathematical functions correlated with PPM4 and PPM6. These data indicate that fMRI responses to behavioral tasks are associated with biochemical properties of the postsynaptic proteome in the respective brain regions.
Postsynaptic composition localizes genetic mechanisms of behavior. Because each BA expresses a specific signature of postsynaptic proteins and human genetic studies show many diseases and behavioral traits are associated with genetic variants in postsynaptic proteins, it follows that combining our proteomic datasets with genetic data may reveal brain regions where those variants exert their influence on phenotypes. If so, this could provide a bridge between genetics and functional brain imaging. To assess this possibility, we used genome-wide association study (GWAS) data on disease and cognitive traits to ask whether variation in the composition of the synaptic proteomes in different BAs would reveal the neocortical localization of these genetically influenced traits. Table 13 on the spatial correlation between that protein's abundance levels and activation. WM, working memory; rf, right foot; rh, right hand; t, tongue; lh, left hand; lf, left foot.
We used summary statistics from some of the largest available GWAS studies to test for association with mental disorders (schizophrenia, autism, Alzheimer's disease, migraine, eating disorders and major depression) and cognitive traits (aggression, years in education and smoking). We also included a set of other traits or disorders including height, type 2 diabetes, cholesterol levels, triglyceride levels, ulcerative colitis, Crohn's disease and inflammatory bowel disease; while these are generally thought of as non-neuronal traits and were intended as controls, some are genetically correlated with core neuronal phenotypes 26 . For each BA, we partitioned the genes into deciles based on their specificity for that region (Fig. 5a,d) , wherein specificity to brain region X is defined as the proportion of the protein's total mean expression that is found in brain region X. We assumed that single-nucleotide polymorphism (SNPs) would primarily influence their nearest genes. Partitioned linkage disequilibrium score regression (LDSC) was used to evaluate the enrichment of the common-variant SNP heritability for each GWAS in each decile. We then tested the hypothesis that disease association increases as brain region specificity increases by fitting a linear model to the enrichment z-scores for each of the deciles.
Prior to multiple correction testing, four GWAS studies showed significant enrichments in heritability as regional specificity increased: smoking (current vs. former) (BA9, P = 0.00012) (Fig. 5b) , schizophrenia (BA11, P = 0.01290), smoking (never vs. ever) (BA44, P = 0.01485) and years in education (BA37, P = 0.02078). Note that the probability is associated with the linear regression, not the enrichments within any particular decile; it implies that the more specific deciles are significantly more associated with the trait than the least specific deciles. After correcting for multiple testing, one region remained significant: BA9, the medial dorsolateral prefrontal cortex, was associated with smoking cessation (P = 0.00012, Fig. 5b) . No other traits (for example, height; Fig. 5c ) were significantly associated with BA9 (nor any other region), nor did other regions show enrichment for smoking (nor other) traits (for example, BA44, Fig. 5e,f) . This result indicates that the postsynaptic proteins that are differentially expressed in BA9 of healthy individuals are encoded by genes that are associated with smoking cessation. Our findings are in agreement with MRI and PET imaging studies that have demonstrated the involvement of BA9 in smoking and substance abuse [27] [28] [29] [30] .
Discussion
We have analyzed the postsynaptic proteome in 12 BAs of the human neocortex and found each one to have a signature of compositional differences that underlie functional differences. Key postsynaptic proteins, including ion channels and neurotransmitter receptors, and biochemical pathways controlling physiology and disease were differentially distributed in neocortical regions. MRI and PET imaging are widely used for structural and functional assessment of brain regions, and we found that regional diversity in postsynaptic proteomes is potentially relevant to the interpretation of these imaging modalities. We also demonstrate that synapse proteome brain maps can be used to link genetics, brain imaging and behavior.
From the compositional differences in the postsynaptic proteome, we see evidence of a molecular logic to the synaptic organization of the neocortex. The postsynaptic proteome is highly Table 1 ). b, Genetic association with smoking (current vs. former smokers) increases in decile groups that are more specific to BA9 (color coded as in a). The two leftmost dots do not represent specificity decile groups; they instead represent, respectively, all SNPs that map onto named regions that are not Human Gene Nomenclature Committee annotated genes and all SNPs that map onto genes whose protein products were not detected in the regional synaptic proteome. The values shown are enrichment values and not enrichment z-scores. Error bars indicate 95% confidence intervals. c, Absence of a genetic association with height as the decile groups become more specific to BA9. d, Distribution of BA44 specificity values for all synaptic proteins divided into deciles (represented by colored blocks). e, Absence of a genetic association with smoking as the decile groups become more specific to BA44. f, Absence of a genetic association with height as the decile groups become more specific to BA44.
complex and comprises a diverse set of protein classes ranging from neurotransmitter receptors, adhesion and scaffold proteins to signaling, metabolic, structural and trafficking proteins [3] [4] [5] [6] 8, 13, [15] [16] [17] 31 . Combinations of these proteins physically assemble into supramolecular multiprotein complexes, which are the building blocks of synapses 9, 12, 32 . We found differential expression of the protein components of complexes, including AMPA, NMDA and GABA receptors, indicating that postsynaptic multiprotein complexes are differentially distributed in neocortical regions. We also found that key components of postsynaptic signaling complexes were in different proteome modules (for example, PPM1 contains GRIN1 and GRIN2B, and PPM2 contains DLG4, DLG3 and DLG2), which are differentially distributed. Using electrophysiological recordings of GABA receptors, we confirmed the differential expression of functional ion channel complexes in synapses from different brain regions. Thus, the regional diversity in postsynaptic proteome composition must reflect the differential allocation of protein complexes into subtypes of synapses and populations of these subtypes define each brain region.
The regional diversity of postsynaptic proteome composition revealed organizational principles. Compositionally distinct areas were found within all four lobes of the cerebrum, with most adjacent regions showing distinct composition. Some regions in different lobes showed similar composition, suggesting anatomically distant regions are composed of synapses with similar signaling properties. The molecular differences between regions are likely to influence the vulnerability of those regions to disease-causing mutations that disrupt postsynaptic proteins 4 . This is supported by the observed enrichments in some regions of disease pathways. Notably, we found enrichments of pathways involved with neurodegeneration and metabolism in similar regions, suggesting that the vulnerability of synapses to neurodegenerative disorders may be influenced by their metabolic properties, consistent with previous results 23 , 33, 34 . While it has been evident from PET and MRI imaging that there is localization of behavioral traits in the neocortex and that these traits have a genetic underpinning, the mechanistic links between genetics, traits and brain regions remain poorly understood. Our finding that GWAS data and synapse proteomics can be combined to identify brain regions associated with smoking is an important proof-of-principle result. The composition of synapse proteomes has not (to our knowledge) been previously considered as a factor in the regional signals of fMRI data. The correlations between the regional localization of postsynaptic compositional signatures and language, mathematical ability and emotional traits support the view that the genetic mechanisms for these traits are associated with the synaptic properties of the cognate brain regions. Given the rich literature describing human brain imaging in behavioral tasks and the advances in genetics of behavior, we expect that more comprehensive datasets will lead to the identification of further links between brain regions, traits and genetics.
Our findings also provide insight into the biological basis of smoking behavior. Our analysis indicates that the ease with which individuals can cease smoking (or their susceptibility to attempting it) may be related to the function of postsynaptic proteins in BA9 in the prefrontal cortex. We also note an interesting potential convergence between smoking, schizophrenia, the dorsolateral prefrontal cortex and the postsynaptic proteome: this brain region is involved with schizophrenia 35 , 80% of schizophrenia patients smoke 36 and genetic susceptibility to schizophrenia is enriched in postsynaptic proteins [37] [38] [39] . The technical obstacles for synapse proteomics from postmortem human brain material have been largely overcome, and it is now feasible to conduct much more detailed examination of human brain regions in normal and diseased tissues. This comparative dataset provides a robust foundation for future studies of the human neocortex in health and disease and is freely available in the Edinburgh DataShare database (http://hdl.handle.net/10283/2811).
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-017-0025-9.
ResouRce
NATuRe NeuRoScIeNce Post-mortem human brain tissue from obtained from the MRC Brain Bank -Edinburgh and processed as previously described 5 . Briefly, dissected tissue was homogenized by performing 12 strokes with a Dounce homogenizer containing 2 mL of ice-cold homogenization buffer (320 mM sucrose, 1 mM HEPES, pH 7.4) containing 1× Complete EDTA-Free Protease Inhibitor (Roche) and 1× Phosphatase Inhibitor Cocktail Set II (Calbiochem). Insoluble material was pelleted by centrifugation at 1,000g for 10 min at 4 °C. The supernatant (S1) was removed, the pellet was resuspended in 1 mL of homogenization buffer and an additional 6 strokes were performed. Following a second centrifugation at 1,000g for 10 min at 4 °C, the supernatant (S2) was removed and pooled with S1. The combined supernatants were then applied to a sucrose gradient to isolate pure PSD fractions suitable for quantitative LC-MS/MS analysis.
Sample preparation and LC-MS/MS analysis.
All chemicals were purchased from Sigma-Aldrich, UK unless otherwise stated. Acetonitrile and water for HPLC-MS/MS and sample preparation were HPLC quality and were purchased from Thermo-Fisher, UK. Formic acid was Suprapure (90-100%) purchased from Merck (Darmstadt, Germany) while trypsin sequencing grade was purchased from Promega (UK). All HPLC-MS connector fittings were purchased either from Upchurch Scientific or Valco (Hichrom and RESTEK, UK). Proteins were acetone precipitated, the pellet reconstituted in 8 M urea and diluted to 2 M, and samples trypsinized in a similar manner as described in ref. 40 . Resulting peptide extracts were then dried under low pressure and acidified with 7 µ l of 0.05% TFA, and were filtered with Millex filter (Millipore, UK) before HPLC-MS analysis. Nano-HPLC-MS/MS analysis was performed using an online system consisting of a nanopump (Dionex Ultimate 3000, Thermo-Fisher, UK) coupled to a QExactive instrument (Thermo-Fisher, UK) with a precolumn of 300 µ m × 5 mm (Acclaim Pepmap, 5 µ m particle size) connected to a column of 75 µ m × 50 cm (Acclaim Pepmap, 3 µ m particle size). Samples were analyzed on a 90-min gradient in data dependent analysis (one survey scan at 70k resolution followed by the top ten MS/MS). Progenesis Version 4 (Nonlinear Dynamics, UK) was used for HPLC-MS label-free quantitation. Only MS/MS peaks with a charge of + 2, + 3 or + 4 were taken into account for the total number of 'Features' (signals at one particular retention time and m/z) and only the five most intense spectra per Feature were included. Each LC-MS run was normalized by multiplying a scalar factor. The scalar factor is a ratio in log space of the median intensity of the selected features against the median intensity of the selected feature of a reference spectrum. The associated unique peptide ion intensities for a specific protein were then summed to generate an abundance value, which was then transformed using an arcsinh function. Based on the abundance values, within-group means were calculated and from there the fold changes (in comparison to control) were evaluated. One-way analysis of variance (ANOVA) was used to calculate the P-value on the basis of the transformed abundance values (see "Statistical analysis"). Differentially expressed proteins were only considered significant in the current study if the following conditions were fulfilled: (i) pair-wise adjusted P < 0.05, (ii) number of unique peptides detected and used in quantification per protein was at least 1 (for the 1,902 dataset) or 2 (for the 1,215 dataset), and (iii) absolute fold change was ≥ 1.5-fold for upregulated proteins and ≤ 0.667 fold for downregulated proteins. Further analysis was performed by a extracting z-score calculated on arcsinh average group.
Data analysis. Data from MS/MS
Preparation of functional synaptosomes from post-mortem human brain tissue. Synaptosomes were purified with a sucrose gradient as described 22 . In brief, human frozen tissue was homogenized ten times with a Teflon homogenizer in 9 ml/g of ice-cold 0.3 M sucrose containing 50 mM Tris-HCl (pH 7.4), 50 mM EGTA, 50 mM EDTA and both protease (Roche) and phosphatase (Calbiochem) inhibitor cocktails. The homogenate was centrifuged at 1,500g for 20 min at 4 °C. The supernatant fraction (S1) was centrifuged at 16,000g for 30 min at 4 °C. The resulting pellet (P2) was resuspended in 5 mM Tris HCl (pH 8.0), homogenized three times with a Teflon homogenizer and left on ice for 45 min. The P2 fraction was homogenized again ten times, resuspended in sucrose to make a 34% (w/w) solution and layered onto a discontinuous sucrose density gradient consisting of, from bottom up, equal volumes of sample and buffer containing 0.85 M and 0.3 M sucrose, respectively. After centrifugation at 60,000g for 2 h with a Beckmann SW41Ti swinging bucket rotor, the synaptosomal fraction (layer between 0.8 and
Assay for measurement of GABA currents from post-mortem human brain tissue. Mature female Xenopus laevis were purchased from Nasco (Fort Atkinson, Wisconsin) and kept in the laboratory of Eli Lilly in the UK. The care and use of the frogs complied with the guidelines of the UK Animals Scientific Procedures Act (1986) and associated guidelines. Oocytes (stages V-VI) were removed from sacrificed frogs and defolliculated after treatment with collagenase type I (5 mg/ml calcium-free Barth's solution) for 4 h at room temperature. 60 nl of synaptosome (1 mg/ml) suspension was injected per oocyte using a Drummond (Broomall, PA) variable volume micro-injector. After injection, oocytes were incubated at 18 °C in a modified Barth's solution containing 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 0.3 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 15 mM HEPES and 50 mg/l neomycin (pH 7.6 with NaOH; osmolarity 235 mOsm). Experiments were performed on oocytes after 2 d of incubation. A total of 5 frogs were used to perform the experiments on Xenopus oocytes.
Oocytes were placed in a recording chamber (internal diameter 3 mm), which was continuously perfused with a saline solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 30 µ M glycine, 10 mM HEPES pH 7.4) at a rate of approximately 10 ml/min. Dilutions of drugs in external saline were prepared immediately before the experiments and applied by switching between control and drug-containing saline using a BPS-8 solution exchange system (ALA Scientific Inc., Westbury, NY). Between responses, the oocytes were washed for 2 min. Oocytes were impaled by two microelectrodes filled with 3 M KCl (0.5-2.5 MΩ ) and voltage-clamped using a Geneclamp 500B amplifier (Axon Instruments, Union City, CA). The external saline was clamped at ground potential by means of a virtual ground circuit using an Ag/AgCl reference electrode and a Pt/Ir currentpassing electrode. The membrane potential was held at − 100 mV. The current needed to keep the oocyte's membrane at the holding potential was measured. Membrane currents were low-pass filtered (four-pole low-pass Bessel filter, − 3 dB at 10 Hz), digitized (50 Hz), and stored on disc for offline computer analysis. Data are expressed as nanoamperes of current (mean ± s.e.m. of n independent experiments). No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications (for example, Mazzo et al. 22 . All experiments were performed at room temperature. Tests of significance were performed using the Student's t-test, and P-values less than 0.05 were considered significant (see "Statistical analysis").
Statistical analysis. LC-MS/MS analysis was performed on 3 μ g of PSD isolates from 12 neocortical regions (n = 12 regions) from 4 donors (n = 4 brains), a total of 48 samples (n = 48) in the entire group. One-way analysis of variance (ANOVA) was used to calculate P-values based on the transformed abundance values. The ANOVA and post hoc t-tests were performed automatically in Progenesis software which automatically normalizes peak intensity. Progenesis software assumes a normal distribution and independency of the samples (n = 12 brain regions). If the data do not meet this requirement, Progenesis marks outlying samples for removal. This did not happen in our data and therefore we assume they meet the criteria for inclusion.
ANOVA was carried out on the median peptide abundances all 48 samples (n = 48), with 1 degree of freedom (1 -N) . No data points were excluded from data analysis. ANOVA values below 0.05 were considered to be statistically significant changes in abundance across all regions. All ANOVA values and corrected P-values are listed in Supplementary Table 2 . Distribution of P-values is shown in Supplementary Fig. 1 .
Two one-sided t-tests (TOST test) were used to assess the nonchanging proteins between the regions of all four individual brains. Using the method of Le Bihan et al. 21 , we performed a TOST test using mean MS intensity values (n = 4) for the 1,213 proteins and an ε sensitivity factor of 0.045, degrees of freedom = 1. Data distribution was assumed to be normal, but this was not formally tested. No data points were excluded from data analysis. The results are presented in Supplementary Table 9. Tukey's HSD test 41 was used to estimate the variability of the mean values between four cases and was performed with FactoMineR (http://factominer.free.fr). Results are presented in Supplementary Fig. 4 .
A two-tailed Student's t-test was used for significance estimation in oocyte experiment, and P-values less than 0.05 were considered significant. Data collection and analysis were not performed blind to the conditions of the experiments. Data distribution was assumed to be normal, but this was not formally tested. No data points were excluded from data analysis. t-values and degrees of freedom of BA39 vs. BA20 and BA19 vs. BA4 are mentioned in the legend of Fig. 2 .
Bioinformatic analysis and visualization. Most analysis was performed in R.
Tukey tests were performed with FactoMineR (http://factominer.free.fr), which provides several useful functions for exploratory multivariate analysis; correlations were visualized with corrplot (https://cran.r-project.org/web/packages/corrplot/ vignettes/corrplot-intro.html); heat maps were generated with the heatmap.2 function from the gplot R library (https://cran.r-project.org/web/packages/gplots/ index.html).
Differential stability (DS) analysis was performed as described 20 : namely, for each protein in the list, an average Pearson correlation coefficient was calculated from six pairwise Pearson coefficients for four brain samples.
Hierarchical clustering and comparison of dendrograms were performed with dendextend, which allows building and comparison of multiple dendrograms 42 . The number of stable clusters was independently assessed with nbClust package 43 , which provides several methods and indices to determine the optimal number of clusters. We selected a set of seven clusters supported by three indices, which was the second-best split. Although the best split (five indices) proposed a two-cluster split, that split was not obviously biologically meaningful or useful.
Cluster robustness was estimated by a bootstrap approach using ClusterCons 44 . Specifically, clustering was performed 1,000 times, removing 20% proteins each time and performing hierarchical clustering using hClust (ward.D), k-means and pam methods. The membership of the clusters obtained was combined and, for each of the individual brains as well as combinations AC, ACD and ABC, compared to assess the specific impact of potential confounders (brains B and D).
We used ClusterProfiler for Gene Ontology (GO) and KEGG enrichment analysis 45 and ReactomePA for pathway over-representation analysis (http:// bioconductor.org/packages/release/bioc/html/ReactomePA.html).
GO enrichment for all protein modules was performed using the ranked list for all proteins identified in a given protein module based on the mean abundances (n = 4), using Gorilla (http://cbl-gorilla.cs.technion.ac.il/). GO enrichment and KEGG pathway enrichment analyses were performed using DAVID (https:// david-d.ncifcrf.gov/) and were searched against a curated list of all previously published mammalian synaptic proteins as the background list. Disease enrichment was performed using Toppcluster (https://toppcluster.cchmc.org/) and KEGG pathway enrichment was then performed by searching ranked protein lists obtained using GSEA v 2.1.0 (http://software.broadinstitute.org/gsea/index.jsp) as previously described 42 . We assessed the nonchanging proteins between the brain regions of all four individuals by performing a TOST test in a similar manner to that previously described 21 , using R (see "Statistical analysis"). An ε equivalency interval of 0.045, where differences within this range are considered substantively unimportant, was used and gave the highest number of hits without including any proteins being identified as significantly differentially expressed between the different brains regions.
Circular hierarchical clustering of protein modules for the visualization of inter-region molecular interactions was performed using Circos (http://circos. ca/) 46 . A Circos configuration file was created representing brain regions as 'karyotypes' . All proteins were grouped into modules according to their abundance similarity. Proteins that had positive abundance in more than one region were shown as links between regions. All preprocessing of the relative abundance information and generation of appropriate Circos files was performed in R.
PET analysis. To assess the significance of correlations between protein abundances with regional PET metabolic parameters 23 , we performed 10,000 reshufflings of the modules (Supplementary Fig. 9 ). The perturbation analysis indicates that the observed correlation with PET data is extremely unlikely to have occurred by chance (resampling-based q < 10
−4
).
MRI and fMRI analysis. MRI and fMRI data from the parcellated human cortex were taken from Glasser et al. 19 via the Human Connectome DB. Corresponding Brodmann maps were generated using the Human Connectome Workbench visualization software developed by Marcus et al. 47 Each BA had many parcels, and we therefore selected those that were most similar to one another by comparing the HCP 'myelin' marker from the fMRI with the expression values of four myelin proteins (MOG, PLP1, OMG and PMP2) in our proteomic data, which were highly correlated (R 2 = 0.7-0.8, P < 0.0001) (Supplementary Fig. 7a ). From a total of 96 parcellated regions, we identified 40 ( Supplementary Fig. 7b and Supplementary Table 14 ) that most significantly correlated with average myelin expression values from our study (n = 12, R 2 = 0.79, P = 0.001865; av1 shown in Supplementary  Fig. 7a ). The HCP structural (myelin and cortical thickness) and behavioral scores for the selected 40 parcels were averaged with respect to the corresponding BAs. For illustration, the four Glasser parcels L_LO1_ROI, L_V2_ROI, L_V3_ROI, BA1 and L_V3CD_ROI were found to match to BA19, so their values for respective functions were averaged and assigned to BA19. As a result, each BA combines values from 2-4 Glasser parcels. These averaged values were tested for Pearson correlation with protein abundances across the 12 BA regions. Correlation scores are shown in Supplementary Table 15 and Fig. 4b . Given the high dimensionality (1,213 × 19) of the task, we performed an additional perturbation analysis to test which of those correlation values were likely to be significant. For that, we shuffled the abundance values for each of the 1,213 proteins a total of 10,000 times to obtain 100,000 matrices of 1,213 proteins with randomly assigned abundance values. Each of 10,000 matrices was correlated to the activity tasks matrix to get 10,000 correlation matrices, which were compared to the original correlation matrix. Following perturbation analysis (10,000× ) and correction for multiple testing, 1,154 values remained significant (resampling-based q < 0.05) (Supplementary Table 16 ). We also correlated the mean abundance values for postsynaptic proteome modules (PPMs) with Glasser terms (Supplementary Fig. 8 ) and, similarly to the analysis for PET (see above), we assessed the significance of correlations by performing 10,000 reshufflings of the module assignment. Each randomized module list was processed to obtain the mean module abundances and correlated with fMRI data. The coefficients with absolute values above 0.53 were significant at the FDR (false discovery rate) level 5%.
Task-fMRI nomenclature. The nomenclature used for the task-fMRI (tfMRI) data is fully described in Glasser et al., Supplementary Information File 3 , Table 3 19 . The tfMRI terms used for comparison with the proteomic data generated in this study are listed and fully described in Supplementary Table 13 . Briefly, the tfMRI data measured the working memory (WM) of individuals tested to recognize images of body (WM_BODY), faces (WM_FACE), places (WM_PLACES) and tools (WM_TOOLS). The ability to match objects based on verbal category (MATCH) and ability to distinguish between two objects (RELATIONAL), as well as response to viewing emotional faces (EMOTION_FACES) versus neutral objects (EMOTION_SHAPES) was also measured. The various motor (MOTOR) function tasks measured by tfMRI were compared with our proteomics data: squeezing of left or right toes (MOTOR_LF_AVG or MOTOR_RF_AVG), tapping of left or right fingers (MOTOR_LH_ABG or MOTOR_RH_AVG), moving the tongue (MOTOR_T_AVG), and average of LF, RF, LH, RH and T (MOTOR_AVG).
Calculation of regional synaptic proteome expression proportion. A key metric used for our genetic enrichment analyzes is the proportion of expression for a given protein in a particular brain region. This is a measure of regional specificity scaled so that a value of 1 implies that the protein is exclusive to a region and a value of 0 implies the protein is not expressed in that region, while if a protein was expressed at the same level in all twelve regions, then each region would have a specificity of 0.083 (1/12). We denote this specificity metric as s g,c for protein g and region c. Values of s g,c were calculated for each HGNC symbol that could be mapped from the RefSeq peptide identifiers; mapping between identifiers was done using biomaRt (https://www.bioconductor.org/packages/devel/bioc/vignettes/ biomaRt/inst/doc/biomaRt.html).
Let us denote that the proteome dataset contains measures from w cells associated with k brain regions. Each of the k regions is associated with a numerical index from the set . . k {1, , }. The region annotations for sample i are stored using a numerical index in L, such that l 1005 = 5 indicates that the 1,005th sample is from the 5th region. We denote N c as the number of samples from the region indexed by c. The expression proportion for protein g and region c (where r g,i is the expression of protein g in sample i) is given by
histocompatibility region because of its unusual gene density (second highest in the human genome) and exceptionally high LD (highest in the genome). The LDSC "munge_sumstats.py" script was used to prepare the summary statistics files. The heritability is then partitioned to each subannotation. We used LD scores calculated for HapMap3 SNPs, excluding the MHC region. All other input files for LD score regression (i.e., 1000 Genomes minor allele frequencies) were obtained from https://data.broadinstitute.org/alkesgroup/LDSCORE/). Partitioned LDSC computes the proportion of heritability associated with each annotation column while taking into account all other annotations. On the basis of the proportion of total SNPs in an annotation, LDSC calculates an enrichment score and an associated enrichment P-value. A linear model was then fit to the enrichment z-scores for the 12 gene categories for each region and GWAS, and the one-tailed probability calculated that the slope is positively associated with increasing regional specificity in the synaptic proteome (as we were only interested in annotations showing enrichments of heritability). The slope of this model is then used to generate the plots in Fig. 5 .
Comparison GWA results for other traits. We included comparisons for a selected set of brain and nonbrain diseases, disorders and traits. The GWA results were from the following sources: autism spectrum disorders and major depression 50 ; schizophrenia 50 Table 5 and 6).
As a second approach, we examined differences between the brain regions of all 4 individuals by performing hierarchical clustering on protein abundances (Supplementary Figure 3) . We also examined the effect of removing brain B (female) or brain D (longest postmortem interval) on biochemical modules. Although this perturbs some modules (specifically modules 5 and 6), we noticed that combining these brains mutually compensated for this disturbance (see section: Neocortical architecture of the postsynaptic proteome; Supplementary Figure 5 ).
We determined that the data from all four individuals could be combined and the mean protein abundances were then used for all downstream analyses.
Our analysis have shown that significant differences in the PSD proteome could, indeed be detected and quantified despite the variation between individuals and that these differences are functionally significant as shown in the Xenopus oocyte GABA receptor assay. Also, results, para 10, and Supp Fig 6. 
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Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). 
